Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Jun;115(3):486–490. doi: 10.1111/j.1476-5381.1995.tb16359.x

Central versus peripheral site of action of the tachykinin NK1-antagonist RP 67580 in inhibiting chemonociception.

U Holzer-Petsche 1, T Rordorf-Nikolić 1
PMCID: PMC1908400  PMID: 7582461

Abstract

1. Many studies indicate an involvement of substance P in the transmission of nociceptive stimuli, without, however, presenting any conclusive evidence as to its exact site and mode of action. The present experiments tested the involvement of substance P in the mediation of chemical nociception using the non-peptidic specific tachykinin NK1-receptor antagonist, RP 67580 (2-[1-imino-2-(2-methoxyphenyl-ethyl]-7,7diphenyl-4-perhydroiso indolone (3aR, 7aR)). 2. Mean arterial pressure (MAP) and intragastric pressure (IGP) were measured in anaesthetized rats. The reflex changes of these parameters in response to i.p. or s.c. injections of hydrochloric acid or capsaicin were taken to indicate nociception. 3. Intravenous administration of RP 67580 up to 5 mg kg-1 had little influence on the reflex changes in MAP or IGP in response to hydrochloric acid or capsaicin. In contrast, the sensitization of rats to i.p. capsaicin by preinjection of prostaglandin E2 was significantly reduced by 1 mg kg-1 RP 67580. 4. Intrathecal injection of 5 micrograms RP 67580 inhibited the reflex changes of MAP and IGP in response to i.p. or s.c. capsaicin whereas the inactive enantiomer RP 68651 was ineffective. 5. The results indicate that spinal NK1-receptors are involved in the acute transmission of chemically induced pain, while such receptors in the periphery take part in the sensitization by prostaglandin E2. The rather minor ability of i.v. RP 67580 to inhibit the acute nociceptive reflex is attributed to an insufficient penetration of the blood-brain-barrier.

Full text

PDF
486

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berge O. G., Ståhlberg M. Is the selective non-peptide NK-1 receptor antagonist CP96,345 a peripherally acting analgesic? Regul Pept. 1993 Jul 2;46(1-2):430–432. doi: 10.1016/0167-0115(93)90110-t. [DOI] [PubMed] [Google Scholar]
  2. Chapman V., Dickenson A. H. The effect of intrathecal administration of RP67580, a potent neurokinin 1 antagonist on nociceptive transmission in the rat spinal cord. Neurosci Lett. 1993 Jul 23;157(2):149–152. doi: 10.1016/0304-3940(93)90724-y. [DOI] [PubMed] [Google Scholar]
  3. Dougherty P. M., Willis W. D. Enhancement of spinothalamic neuron responses to chemical and mechanical stimuli following combined micro-iontophoretic application of N-methyl-D-aspartic acid and substance P. Pain. 1991 Oct;47(1):85–93. doi: 10.1016/0304-3959(91)90015-P. [DOI] [PubMed] [Google Scholar]
  4. Fardin V., Foucault F., Bock M. D., Jolly A., Flamand O., Clerc F., Garret C. Variations in affinities for the NK1 receptor: differences between the non-peptide substance P antagonists RP 67580 and CP-96,345 and the agonist septide. Regul Pept. 1993 Jul 2;46(1-2):300–303. doi: 10.1016/0167-0115(93)90066-h. [DOI] [PubMed] [Google Scholar]
  5. Fong T. M., Yu H., Strader C. D. Molecular basis for the species selectivity of the neurokinin-1 receptor antagonists CP-96,345 and RP67580. J Biol Chem. 1992 Dec 25;267(36):25668–25671. [PubMed] [Google Scholar]
  6. Garret C., Carruette A., Fardin V., Moussaoui S., Peyronel J. F., Blanchard J. C., Laduron P. M. Pharmacological properties of a potent and selective nonpeptide substance P antagonist. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10208–10212. doi: 10.1073/pnas.88.22.10208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Garret C., Carruette A., Fardin V., Moussaoui S., Peyronel J. F., Blanchard J. C., Laduron P. M. RP 67580, un antagoniste, non peptidique, puissant et sélectif de la substance P. C R Acad Sci III. 1992;314(5):199–204. [PubMed] [Google Scholar]
  8. Holzer-Petsche U. Blood pressure and gastric motor responses to bradykinin and hydrochloric acid injected into somatic or visceral tissues. Naunyn Schmiedebergs Arch Pharmacol. 1992 Aug;346(2):219–225. doi: 10.1007/BF00165305. [DOI] [PubMed] [Google Scholar]
  9. Kessler W., Kirchhoff C., Reeh P. W., Handwerker H. O. Excitation of cutaneous afferent nerve endings in vitro by a combination of inflammatory mediators and conditioning effect of substance P. Exp Brain Res. 1992;91(3):467–476. doi: 10.1007/BF00227842. [DOI] [PubMed] [Google Scholar]
  10. Laird J. M., Hargreaves R. J., Hill R. G. Effect of RP 67580, a non-peptide neurokinin1 receptor antagonist, on facilitation of a nociceptive spinal flexion reflex in the rat. Br J Pharmacol. 1993 Jul;109(3):713–718. doi: 10.1111/j.1476-5381.1993.tb13632.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lecci A., Giuliani S., Patacchini R., Viti G., Maggi C. A. Role of NK1 tachykinin receptors in thermonociception: effect of (+/-)-CP 96,345, a non-peptide substance P antagonist, on the hot plate test in mice. Neurosci Lett. 1991 Aug 19;129(2):299–302. doi: 10.1016/0304-3940(91)90485-c. [DOI] [PubMed] [Google Scholar]
  12. Lotz M., Carson D. A., Vaughan J. H. Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis. Science. 1987 Feb 20;235(4791):893–895. doi: 10.1126/science.2433770. [DOI] [PubMed] [Google Scholar]
  13. Marriott D., Wilkin G. P., Coote P. R., Wood J. N. Eicosanoid synthesis by spinal cord astrocytes is evoked by substance P; possible implications for nociception and pain. Adv Prostaglandin Thromboxane Leukot Res. 1991;21B:739–741. [PubMed] [Google Scholar]
  14. Mjellem-Joly N., Lund A., Berge O. G., Hole K. Intrathecal co-administration of substance P and NMDA augments nociceptive responses in the formalin test. Pain. 1992 Nov;51(2):195–198. doi: 10.1016/0304-3959(92)90260-I. [DOI] [PubMed] [Google Scholar]
  15. Nakamura-Craig M., Smith T. W. Substance P and peripheral inflammatory hyperalgesia. Pain. 1989 Jul;38(1):91–98. doi: 10.1016/0304-3959(89)90078-X. [DOI] [PubMed] [Google Scholar]
  16. Nicol G. D., Klingberg D. K., Vasko M. R. Prostaglandin E2 increases calcium conductance and stimulates release of substance P in avian sensory neurons. J Neurosci. 1992 May;12(5):1917–1927. doi: 10.1523/JNEUROSCI.12-05-01917.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Otsuka M., Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol Rev. 1993 Apr;73(2):229–308. doi: 10.1152/physrev.1993.73.2.229. [DOI] [PubMed] [Google Scholar]
  18. Prabhakar N. R., Cao H., Lowe J. A., 3rd, Snider R. M. Selective inhibition of the carotid body sensory response to hypoxia by the substance P receptor antagonist CP-96,345. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10041–10045. doi: 10.1073/pnas.90.21.10041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Radhakrishnan V., Henry J. L. Novel substance P antagonist, CP-96,345, blocks responses of cat spinal dorsal horn neurons to noxious cutaneous stimulation and to substance P. Neurosci Lett. 1991 Oct 28;132(1):39–43. doi: 10.1016/0304-3940(91)90428-v. [DOI] [PubMed] [Google Scholar]
  20. Rupniak N. M., Boyce S., Williams A. R., Cook G., Longmore J., Seabrook G. R., Caeser M., Iversen S. D., Hill R. G. Antinociceptive activity of NK1 receptor antagonists: non-specific effects of racemic RP67580. Br J Pharmacol. 1993 Dec;110(4):1607–1613. doi: 10.1111/j.1476-5381.1993.tb14008.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rusin K. I., Bleakman D., Chard P. S., Randic M., Miller R. J. Tachykinins potentiate N-methyl-D-aspartate responses in acutely isolated neurons from the dorsal horn. J Neurochem. 1993 Mar;60(3):952–960. doi: 10.1111/j.1471-4159.1993.tb03242.x. [DOI] [PubMed] [Google Scholar]
  22. Rusin K. I., Ryu P. D., Randic M. Modulation of excitatory amino acid responses in rat dorsal horn neurons by tachykinins. J Neurophysiol. 1992 Jul;68(1):265–286. doi: 10.1152/jn.1992.68.1.265. [DOI] [PubMed] [Google Scholar]
  23. Szolcsányi J., Nagy J., Pethö G. Effect of CP-96,345 a non-peptide substance P antagonist, capsaicin, resiniferatoxin and ruthenium red on nociception. Regul Pept. 1993 Jul 2;46(1-2):437–439. doi: 10.1016/0167-0115(93)90112-l. [DOI] [PubMed] [Google Scholar]
  24. Yamamoto T., Shimoyama N., Mizuguchi T. Effects of FK224, a novel cyclopeptide NK1 and NK2 antagonist, and CP-96,345, a nonpeptide NK1 antagonist, on development and maintenance of thermal hyperesthesia evoked by carrageenan injection in the rat paw. Anesthesiology. 1993 Nov;79(5):1042–1050. doi: 10.1097/00000542-199311000-00023. [DOI] [PubMed] [Google Scholar]
  25. Yamamoto T., Yaksh T. L. Stereospecific effects of a nonpeptidic NK1 selective antagonist, CP-96,345: antinociception in the absence of motor dysfunction. Life Sci. 1991;49(26):1955–1963. doi: 10.1016/0024-3205(91)90637-q. [DOI] [PubMed] [Google Scholar]
  26. Yashpal K., Radhakrishnan V., Coderre T. J., Henry J. L. CP-96,345, but not its stereoisomer, CP-96,344, blocks the nociceptive responses to intrathecally administered substance P and to noxious thermal and chemical stimuli in the rat. Neuroscience. 1993 Feb;52(4):1039–1047. doi: 10.1016/0306-4522(93)90550-y. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES